Endocrinology Consultant spoke with Christian Hampp, PhD, from the US Food and Drug Administration, whose study found high rates of diabetic ketoacidosis when sodium-glucose cotransporter 2 inhibitors are...
Endocrinology Consultant spoke with James Rosenzweig, MD, chair of the task force that developed the Endocrine Society’s clinical practice guideline for the primary prevention of atherosclerotic...
Neal Barnard, MD, President of the Physicians Committee for Responsible Medicine, discusses evidence on the key role of plant-based eating patterns in the treatment of diabetes, as well as the importance of...
Kim Carmichael, MD, from the Washington University School of Medicine in St. Louis, discusses his column, “What Do You Need to Know About Diabetic Gastroparesis?”
New research suggests many older adults with type 2 diabetes believe factors including longer disease duration, more established complications, and more comorbidities warrant more aggressive diabetes...
Recent research suggests very few eligible individuals who express interest in a diabetes prevention program are actually referred or participate, despite their effectiveness. Consultant360 spoke with lead...
In this podcast, Lucia Novak reflects on how the ACP's 2018 HbA1c guidelines have impacted the landscape of diabetes care over the past year, and discusses the importance of individualized treatment.
Lucia Novak, director of Riverside Diabetes Center, gives strategies that may help improve diabetes management and prevent clinical inertia on patient and practitioner levels.
Lucia Novak, director of Riverside Diabetes Center, discusses the benefits of long-acting insulins and barriers that may prevent more widespread implementation of these therapies.
